Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans

Clinical Infectious Diseases

Volumn 24, Issue 2, 1997, Pages 124-130

  Laguna, Fernando ^a   Rodríguez Tudela, Juan L ^b   Martínez Suárez, Joaquin V ^b   Polo, Rosa ^b   Valencia, Eulalia ^b   Diaz Guerra, Teresa M ^b   Dronda, Fernando ^b   Pulido, Federico ^b  

^a Servicio de Enfermedades Infecciosas   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ADULT; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; T LYMPHOCYTE; THRUSH;

EID: 0031056468     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.2.124     Document Type: Article

References (16)

1. Miyasaki SH, Hicks JB, Greenspan D, et al. The identification and tracking of Candida albicans isolates fron oral lesions in HIV-seropositive individuals. J Acquir Immun Defic Syndr 1992:5:1039-46.
2. De Witt S, Weerts D, Goossens H, Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989; 1:746-8.
3. Laine L, Dretler RH, Conteas CN, et al. Fluconazole compared with keto-. conazole for the treatment of Candida esophagitis in AIDS: a randomized trial. Ann Intern Med 1992; 117:655-60.
4. Smith DE, Midgley J, Allan M, Connolly GM, Gazzard BG. Itraconazole versus ketoconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. AIDS 1991;5:1367-71.
5. Galgiani JN. Fluconazole, a new antifungal agent [editorial]. Ann Intern Med 1990; 113:177-9.
6. Laine L. The natural history of esophageal candidiasis after successful treatment in patients with AIDS. Gastroenterology 1994; 107:744-6.
7. Marriott DJE, Jones PD, Hoy JF, Speed BR, Harkness JL. Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients: a double-blind placebo-controlled study. Med J Aust 1993; 158:312-6.
8. Leen CLS, Dunbar EM, Ellis ME, Mandal BK. Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. J Infect 1990;21:55-60.
9. Stevens DA, Greene SI, Lang OS. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Arch Intern Med 1991; 151: 2458-64.
10. Lavilla P, Gil A, Valencia E, et al. Profilaxis secundaria de la candidiasis esofágica con fluconazol en el síndrome de inmunodeficiencia adquirida. Rev Clin Esp 1992; 190:115-9.
11. Boken DJ, Swindells S, Rinaldi MG. Fluconazole-resistant Candida albicans. Clin Infect Dis 1993; 17:1018-21.
12. Dronda F, Rodríguez-Tudela JL, Mera P, Martínez-Suárez J. Esofagilis por Candida albicans resistente a fluconazol: fracaso terapeútico y correlacion in vitro [letter]. Med Clin (Barc) 1992;5:199.
13. Dupouy-Camet J, Paugam A, Di Donato C, et al. Resistance au fluconazole en milieu hospitalier. Concordance entre la resistance de Candida albicans in vitro et l' échec thérapeutique [letter]. Presse Medicale 1991; 20:1341.
14. Fox R, Neal KR, Leen CLS, Ellis ME, Mandal BK. Fluconazole resistant Candida in AIDS [letter]. J Infect 1991;22:201-4.
15. Kitchen VS, Savage M, and Harris JRW. Candida albicans resistance in AIDS [letter]. J Infect 1991;22:204-5.
16. Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994; 18:240-2.